About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:7596076
Allelic
Composition
Sdhaf4em1Bcgen/Sdhaf4em1Bcgen
Tg(Ckmm-cre)5Khn/0
Genetic
Background
B6.Cg-Sdhaf4em1Bcgen Tg(Ckmm-cre)5Khn
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sdhaf4em1Bcgen mutation (0 available); any Sdhaf4 mutation (6 available)
Tg(Ckmm-cre)5Khn mutation (4 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• none survive past 12 weeks of age
• treatment with sodium fumarate dibasic or Mdivi-1 (a specific Dnm1l inhibitor) to target mitochondria substantially prolongs the survival of the mice

cardiovascular system
• severe abnormalities in myofibril/sarcomere organization and intramitochondrial structure at 8 weeks of age
• despite the increase in number of mitochondria the amount of mtDNA is reduced
• at 8 weeks of age cristae malformations, electron-dense inclusions and hypodense compartments are seen
• at 8 weeks of age the number of mitochondria is increased and the size is decreased
• treatment with sodium fumarate dibasic or Mdivi-1 (a specific Dnm1l inhibitor) improves mitochondrial morphology
• in cardiomyocytes at 8 weeks of age
• thickening of the cardiac muscle by 3-4 weeks of age
• starting at 3 weeks of age
• develops at later stages
• present at 7 weeks but not at 4 weeks of age
• at later stages
• upregulation of pathological markers is seen primarily in the left ventricle
• deregulated cardiac contraction
• treatment with Mdivi-1 (a specific Dnm1l inhibitor) improves cardiac function
• decrease in left ventricular fractional shortening

growth/size/body
• starting at 3 weeks of age
• lower body weights in mice older than 6 weeks
• no difference in body weight is detected during the first 6 weeks of life
• ratio of tibialis anterior muscle weight to body weight is similar to controls

cellular
• at 8 weeks of age cristae malformations, electron-dense inclusions and hypodense compartments are seen
• at 8 weeks of age the number of mitochondria is increased and the size is decreased
• despite the increase in number of mitochondria the amount of mtDNA is reduced
• treatment with sodium fumarate dibasic or Mdivi-1 (a specific Dnm1l inhibitor) improves mitochondrial morphology
• in cardiomyocytes at 8 weeks of age
• mitochondrial dysfunction in the heart indicated by expression analysis, increase in protein oxidation, and decreases in TCA cycle related metabolites
• analysis of posttranslational modification of Dnm1l and other results suggest an increase in mitochondrial fission
• deregulated TCA cycle in cardiomyocytes

muscle
• severe abnormalities in myofibril/sarcomere organization and intramitochondrial structure at 8 weeks of age
• at 8 weeks of age cristae malformations, electron-dense inclusions and hypodense compartments are seen
• at 8 weeks of age the number of mitochondria is increased and the size is decreased
• despite the increase in number of mitochondria the amount of mtDNA is reduced
• treatment with sodium fumarate dibasic or Mdivi-1 (a specific Dnm1l inhibitor) improves mitochondrial morphology
• in cardiomyocytes at 8 weeks of age
• thickening of the cardiac muscle by 3-4 weeks of age
• at later stages
• upregulation of pathological markers is seen primarily in the left ventricle
• deregulated cardiac contraction
• treatment with Mdivi-1 (a specific Dnm1l inhibitor) improves cardiac function
• decrease in left ventricular fractional shortening

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy DOID:12930 OMIM:PS115200
J:345348


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory